Table 1.
COVID-19 and vaccination status for the cohorts under consideration.
| Donor Type | Cohort | Days from Disease Onset | N | Recollection Time | Expected COVID-19 Variants | Vaccinated |
|---|---|---|---|---|---|---|
| Hospitalized COVID-19 patients | AC0 | 0 | 697 | Apr–Dec 2020 | FL, α, β | No |
| RE0 | (0,7], (7–14], (14–30], (30,60], >60, TOT | 137, 96, 104, 97, 10, 444 | FL, α, β | No | ||
| AC1 | 0 | 189 | Jan–Oct 2021 | γ, δ | Mixed | |
| RE1 | (0,7], (7–14], (14–30], (30,60], >60, TOT | 100,1,15, 158, 79, 353 | γ, δ | Mixed | ||
| General population | HC | no COVID | 8664 | Before 2020 | none | No |
| NHR1 | (7–14], (30,60], >60, TOT |
1, 16, 78, 95 | Jun–Nov 2021 | δ, ο | No | |
| NHRV1 | (0,7], (7–14], (14–30], (30,60], >60, TOT | 1, 2, 8, 27, 380, 418 | Jun–Dec 2021 | δ, ο | Yes | |
| HC1 | no COVID | 238 | May–Nov 2021 | none | No | |
| HCV1 | no COVID | 2322 | May–Dec 2021 | none | Yes |
Abbreviations: TOT, total number; FL, first Lineage; α, alpha/B1.1.7; β, beta/B.1.351, γ, gamma/P.1, δ, delta/B1.617.2; ο, omicron/BA.1/2.